Acadian Asset Management
MNTA

Acadian Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Acadian Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-157,007
Closed -$2.85M – 1915
2018
Q1 		$2.85M Sell
157,007
-138,330
-47% -$2.31M 0.01% 521
2017
Q4 		$4.12M Sell
295,337
-234,860
-44% -$3.17M 0.02% 403
2017
Q3 		$9.81M Sell
530,197
-165,941
-24% -$2.77M 0.04% 282
2017
Q2 		$11.8M Buy
696,138
+531,525
+323% +$8.09M 0.05% 263
2017
Q1 		$2.2M Buy
+164,613
New +$2.58M 0.01% 590

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Acadian Asset Management's MNTA Position: Q2 2018 in Review

Acadian Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2018, closing a stake of 157,007 shares — an estimated $2.85M sold.

Acadian Asset Management first reported a position in MNTA in Q1 2017 and held it in 5 quarters. The position peaked at $11.8M in Q2 2017. 160 funds tracked by Wall St. Rank hold MNTA as of Q2 2018.

  • Acadian Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Acadian Asset Management sold 157,007 Momenta Pharmaceuticals, Inc. shares in Q2 2018, an estimated $2.85M.
  • Acadian Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2017 and held it in 5 quarters.
  • Acadian Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $11.8M in Q2 2017.
  • 160 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2018.

Based on Acadian Asset Management's 13F filing for Q2 2018, filed 24 Jul 2018.